Yüklüyor......
Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome
INTRODUCTION: Sjögren-Larsson syndrome (SLS) is a rare neurocutaneous disease characterized by ichthyosis, spasticity, intellectual disability and a distinctive retinopathy. It is caused by inactivating mutations in ALDH3A2, which codes for fatty aldehyde dehydrogenase (FALDH) and results in abnorma...
Kaydedildi:
| Yayımlandı: | Expert Opin Orphan Drugs |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4989507/ https://ncbi.nlm.nih.gov/pubmed/27547594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/21678707.2016.1154453 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|